Loading...
PG logo

The Procter & Gamble CompanyNYSE:PG Stok Raporu

Piyasa Değeri US$332.3b
Hisse Fiyatı
US$141.57
US$164.09
13.7% değerinin altında içsel indirim
1Y-13.3%
7D-3.3%
Portföy Değeri
Görünüm

The Procter & Gamble Company

NYSE:PG Stok Raporu

Piyasa değeri: US$332.3b

PG Community Fair Values

Create Narrative

See what 564 others think this stock is worth. Follow their fair value or set your own to get alerts.

The Procter & Gamble Company Rakipler

Fiyat Geçmişi ve Performans

Hisse fiyatlarındaki yükseliş, düşüş ve değişimlerin özeti Procter & Gamble
Tarihsel hisse senedi fiyatları
Güncel Hisse FiyatıUS$141.57
52 Haftanın En Yüksek SeviyesiUS$170.99
52 Haftanın En Düşük SeviyesiUS$137.62
Beta0.40
1 Aylık Değişim-1.26%
3 Aylık Değişim-11.56%
1 Yıllık Değişim-13.30%
3 Yıllık Değişim-7.57%
5 Yıllık Değişim2.59%
Halka arzdan bu yana değişim9,642.46%

Son Haberler & Güncellemeler

Anlatı Güncellemesi May 04

PG: Brand Partnerships And Product Pipeline Will Support Future Shareholder Returns

Analysts have trimmed their Procter & Gamble price target slightly to about $164.09, reflecting modestly lower assumptions for revenue and profit margins while applying a slightly higher future P/E outlook. What's in the News P&G maintained fiscal 2026 guidance, with all-in sales growth expected in a 1% to 5% range and diluted EPS growth targeted in a 1% to 6% range versus fiscal 2025 diluted EPS of US$6.51 (Corporate guidance).

Recent updates

Anlatı Güncellemesi May 04

PG: Brand Partnerships And Product Pipeline Will Support Future Shareholder Returns

Analysts have trimmed their Procter & Gamble price target slightly to about $164.09, reflecting modestly lower assumptions for revenue and profit margins while applying a slightly higher future P/E outlook. What's in the News P&G maintained fiscal 2026 guidance, with all-in sales growth expected in a 1% to 5% range and diluted EPS growth targeted in a 1% to 6% range versus fiscal 2025 diluted EPS of US$6.51 (Corporate guidance).
Seeking Alpha Apr 25

Procter & Gamble: Fundamentals Are Solid, But The Price Is Too High - Downgrading From Buy To Hold

Summary Procter & Gamble is downgraded from buy to hold due to macroeconomic headwinds and valuation concerns. PG continues to deliver robust, broad-based organic sales growth of 3%, with strength in both volume and pricing. The company’s growth is well-diversified across regions and product categories, underscoring resilience despite poor consumer confidence. Current valuation does not adequately reflect heightened macro uncertainty, making a hold rating more justifiable at this time. Read the full article on Seeking Alpha
Yeni Anlatı Apr 24

Procter & Gamble (PG): The Beauty-Driven Beat and the Resilience of Staples

Procter & Gamble (PG) , the global vanguard of consumer staples, enters the afternoon of Friday, April 24, 2026 , as a beacon of stability following its Q3 Fiscal 2026 earnings report released this morning. The Cincinnati-based giant delivered a solid "beat-and-raise" performance, reporting Core EPS of $1.59 , surpassing the Wall Street consensus of $1.56.
Anlatı Güncellemesi Apr 20

PG: Buybacks And Brand Partnerships Will Support Future Shareholder Returns

Analysts have slightly reduced their price target on Procter & Gamble to $164.18 from $166.95, reflecting modestly lower assumptions for revenue growth, profit margins, fair value, and future P/E multiples. What's in the News P&G revised its fiscal 2026 diluted EPS growth outlook to a range of 1% to 6%, from a prior range of 3% to 9%, citing higher non core restructuring charges, while keeping all in sales growth guidance at 1% to 5% versus the prior year (Corporate guidance).
Anlatı Güncellemesi Apr 05

PG: Share Repurchases And Premium Portfolio Refresh Will Support Future Returns

Analysts have slightly reduced their average price target for Procter & Gamble to about $167 from $168, reflecting updated views on margins and forward P/E assumptions while keeping core growth expectations largely intact. What's in the News OLAY shared new skin aging research at the 2026 American Academy of Dermatology meeting, focusing on cell adhesion as a key factor in visible aging and applying these findings to peptide based products across the Regenerist line and the new Regenerist Treatments collection (Product announcement).
Anlatı Güncellemesi Mar 22

PG: Product Refresh And Buybacks Will Support Future Earnings Resilience

Analysts kept their Procter & Gamble price target steady at $168. This reflects largely unchanged views on fair value, discount rate, revenue growth, profit margin, and future P/E assumptions.
Anlatı Güncellemesi Mar 08

PG: Brand Refresh And Buybacks Will Support Stable Earnings Outlook

Analysts have maintained their Procter & Gamble price target at $168, reflecting unchanged assumptions around revenue growth, profit margins, and future P/E. This suggests that recent research has not materially shifted their valuation view.
Anlatı Güncellemesi Feb 21

PG: Brand Activity And Buybacks Will Support Stable Margins And Outlook

Analysts have nudged their price target for Procter & Gamble higher to $168.00 from $167.45, reflecting updated assumptions for revenue growth, slightly higher profit margins and a marginally lower future P/E multiple. What's in the News Tide launched Tide evo, a 100% concentrated, waterless laundry tile with six cleaning layers and no plastic bottles, positioned to address demand for products that align with hygiene and sustainability preferences in the U.S. (Product related announcement) Head & Shoulders introduced BARE Itchy Scalp Relief Serum, aimed at providing clinically tested dandruff protection and itch relief between washes, with a nationwide U.S. launch planned for January 2026.
Anlatı Güncellemesi Feb 07

PG: Premium Brand Extensions And Stable Margins Will Support A Balanced Outlook

Analysts have nudged their price target on Procter & Gamble slightly higher to US$167.45 from about US$165.32, reflecting updated assumptions for fair value, discount rate, revenue growth, profit margins and future P/E. What's in the News Old Spice launched the Spice Alchemist collection, a premium cologne-infused deodorant, body wash and body mist line positioned against high end fragrances.
Anlatı Güncellemesi Jan 25

Q2 2026 Update

Update narrative with most recent financial statements.
Anlatı Güncellemesi Jan 23

PG: Share Repurchases And Margin Pressures Will Shape A Balanced Outlook

Analysts have trimmed their price target on Procter & Gamble to US$165 from US$168, citing updated views on revenue growth, profit margins, and the future P/E multiple. What's in the News P&G updated its fiscal 2026 guidance, keeping all in sales growth for the year in a range of 1% to 5% versus the prior year, while lowering the diluted EPS growth outlook to 1% to 6% from the previous 3% to 9% range, citing higher non core restructuring charges versus fiscal 2025 diluted EPS of US$6.51 (Corporate guidance).
Anlatı Güncellemesi Jan 07

PG: Share Repurchase Will Support Future Upside With Stable Long Term Outlook

Narrative Update on Procter & Gamble The analyst price target for Procter & Gamble has shifted slightly, with updated assumptions around fair value at about $168.13, discount rate at 6.96%, revenue growth at roughly 3.12%, profit margin near 19.58%, and future P/E around 26.08x, as analysts fine tune their models on the company. What's in the News Pantene is partnering again with social media creator Alix Earle to promote the Abundant & Strong 3-Step System, including limited-edition Alix x Pantene Kits that bundle the three products with a free cosmetics bag and hairbrush for a limited time (product-related announcement).
Anlatı Güncellemesi Dec 16

PG: Share Repurchase Will Support Future Upside Amid Stable Long Term Outlook

Analysts have nudged their price target for Procter & Gamble slightly lower to approximately $168.50 from about $169.05, reflecting modestly softer long term revenue growth expectations that are only partially offset by a marginally improved profit margin outlook and a slightly lower assumed future valuation multiple. What's in the News Pantene launched the Abundant & Strong Collection, a three step system clinically shown to reduce hair loss by up to 85% by targeting scalp oxidative stress with a Pro Vitamin Complex plus Niacinamide technology.
Anlatı Güncellemesi Dec 02

PG: Share Repurchase And New Collections Will Drive Continued Momentum

Procter & Gamble's analyst price target remains unchanged at $169.05 as analysts maintain stable estimates based on consistent fair value metrics and minimal adjustments to key financial assumptions. What's in the News Pantene launches the Abundant & Strong Collection, a new three-step system designed to reduce hair loss by up to 85% and promote stronger, denser hair using antioxidant technology.
Anlatı Güncellemesi Nov 18

PG: Share Buybacks And New Guidance Will Support Steady Uptrend

Analysts have maintained Procter & Gamble's price target at $169.05 per share. There have been only minor adjustments to underlying valuation factors, supporting a steady outlook for the company.
Anlatı Güncellemesi Nov 03

PG: Share Buyback And Product Rollout Will Drive Long-Term Upside

Analysts have slightly raised their price target for Procter & Gamble to $169.05 from $168.64. They cite incremental improvements in revenue growth forecasts even as profit margin projections moderate.
Anlatı Güncellemesi Oct 20

Rising Consumer Confidence And Product Investment Will Expand US Markets

Analysts have slightly lowered their price target for Procter & Gamble from $170.95 to $168.64 per share. They cite modest reductions in projected revenue growth, which are partially offset by improved profit margins and valuation multiples.
Analiz Makalesi Aug 06

The Procter & Gamble Company (NYSE:PG) Just Reported Full-Year Earnings: Have Analysts Changed Their Mind On The Stock?

NYSE:PG 1 Year Share Price vs Fair Value Explore Procter & Gamble's Fair Values from the Community and select yours The...
User avatar
Yeni Anlatı Jul 21

Procter & Gamble: A Dividend Giant Facing Slowing Growth

United States: 48.21%1-Year Revenue Growth = 4.65%
Analiz Makalesi Jun 27

The Procter & Gamble Company (NYSE:PG) Shares Could Be 21% Below Their Intrinsic Value Estimate

Key Insights The projected fair value for Procter & Gamble is US$200 based on 2 Stage Free Cash Flow to Equity Procter...
Seeking Alpha Apr 22

Procter & Gamble: Hold This Stodgy Stalwart

Summary Procter & Gamble is a global consumer product leader, with a strong market presence and consistent, albeit slow, growth in revenue and earnings. Despite being overvalued, PG's profitability remains robust, with reliable cash flow and a solid gross profit margin above industry medians. PG's valuation poses a risk, with a high PEG ratio indicating slow growth, yet it maintains a decent dividend yield and outpaces peers in performance. PG is a safe investment but lacks excitement; it's a hold due to its steady but lethargic growth and overvaluation concerns. Read the full article on Seeking Alpha

Hissedar Getirileri

PGUS Household ProductsUS Pazar
7D-3.3%-3.0%-0.9%
1Y-13.3%-14.2%24.4%

Getiri vs. Endüstri: PG geçen yıl boyunca % -14.2 oranında getiri sağlayan US Household Products sektörüyle eşleşti.

Getiri vs Piyasa: PG geçen yıl % 24.4 oranında getiri sağlayan US Piyasasının altında performans gösterdi.

Fiyat Oynaklığı

Is PG's price volatile compared to industry and market?
PG volatility
PG Average Weekly Movement3.1%
Household Products Industry Average Movement3.5%
Market Average Movement7.2%
10% most volatile stocks in US Market16.2%
10% least volatile stocks in US Market3.1%

İstikrarlı Hisse Senedi Fiyatı: PG son 3 ayda US piyasasına kıyasla önemli bir fiyat oynaklığı yaşamadı.

Zaman İçindeki Volatilite: PG 'nin haftalık oynaklığı ( 3% ) son bir yıldır istikrarlı seyretti.

Şirket Hakkında

KurulduÇalışanlarCEOWeb sitesi
1837109,000Shailesh Jejurikarwww.pginvestor.com

The Procter & Gamble Company, dünya çapında markalı ambalajlı tüketici ürünleri sunmaktadır. Güzellik; Bakım; Sağlık; Kumaş ve Ev Bakımı; ve Bebek, Kadın ve Aile Bakımı segmentlerinde faaliyet göstermektedir. Şirket Head & Shoulders, Herbal Essences, Pantene ve Rejoice markaları altında saç kremleri, şampuanlar, şekillendirme yardımcıları ve bakım ürünleri; Native, Old Spice, Safeguard ve Secret markaları altında ter önleyiciler, deodorantlar ve kişisel temizlik ürünleri; Olay ve SK-II markaları altında yüz nemlendiricileri, temizleyiciler ve bakım ürünleri sunmaktadır.

The Procter & Gamble Company Temel Bilgiler Özeti

Procter & Gamble'un kazançları ve gelirleri piyasa değeriyle nasıl karşılaştırılır?
PG temel i̇stati̇sti̇kler
Piyasa değeriUS$332.31b
Kazançlar(TTM)US$16.32b
Gelir(TTM)US$86.72b
20.2x
F/K Oranı
3.8x
P/S Oranı

Kazanç ve Gelir

En son kazanç raporundan temel karlılık istatistikleri (TTM)
PG gelir tablosu (TTM)
GelirUS$86.72b
Gelir MaliyetiUS$42.51b
Brüt KârUS$44.21b
Diğer GiderlerUS$27.89b
KazançlarUS$16.32b

Son Raporlanan Kazançlar

Mar 31, 2026

Sonraki Kazanç Tarihi

Jul 29, 2026

Hisse başına kazanç (EPS)7.01
Brüt Marj50.98%
Net Kâr Marjı18.82%
Borç/Özkaynak Oranı67.7%

PG uzun vadede nasıl bir performans gösterdi?

Geçmiş performansı ve karşılaştırmayı görün

Temettüler

3.1%
Mevcut Temettü Verimi
61%
Ödeme Oranı

PG güvenilir bir temettü ödüyor mu?

PG temettü geçmişine ve kıyaslamalara bakın
Yaklaşan bir temettüyü almak için ne zaman PG satın almanız gerekir?
Procter & Gamble temettü tari̇hleri̇
Eski Temettü TarihiApr 24 2026
Temettü Ödeme TarihiMay 15 2026
Eski temettüye kadar geçen günler23 days
Temettü ödeme tarihine kadar geçen günler2 days

PG güvenilir bir temettü ödüyor mu?

PG temettü geçmişine ve kıyaslamalara bakın

Şirket Analizi ve Finansal Veri Durumu

VeriSon Güncelleme (UTC saati)
Şirket Analizi2026/05/15 13:25
Gün Sonu Hisse Fiyatı2026/05/15 00:00
Kazançlar2026/03/31
Yıllık Kazançlar2025/06/30

Veri Kaynakları

Şirket analizimizde kullanılan veriler S&P Global Market Intelligence LLC'den alınmıştır. Bu raporu oluşturmak için analiz modelimizde aşağıdaki veriler kullanılmıştır. Veriler normalize edilmiştir, bu da kaynağın mevcut olmasından kaynaklanan bir gecikmeye neden olabilir.

PaketVeriZaman ÇerçevesiÖrnek ABD Kaynağı *
Şirket Finansalları10 yıl
  • Gelir tablosu
  • Nakit akış tablosu
  • Bilanço
Analist Konsensüs Tahminleri+3 yıl
  • Finansal tahminler
  • Analist fiyat hedefleri
Piyasa Fiyatları30 yıl
  • Hisse senedi fiyatları
  • Temettüler, Bölünmeler ve Eylemler
Sahiplik10 yıl
  • En büyük hissedarlar
  • İçeriden öğrenenlerin ticareti
Yönetim10 yıl
  • Liderlik ekibi
  • Yönetim Kurulu
Önemli Gelişmeler10 yıl
  • Şirket duyuruları

* ABD menkul kıymetleri için örnek, ABD dışı için eşdeğer düzenleyici formlar ve kaynaklar kullanılmıştır.

Belirtilmediği sürece tüm finansal veriler yıllık bir döneme dayanmaktadır ancak üç ayda bir güncellenmektedir. Bu, İzleyen On İki Ay (TTM) veya Son On İki Ay (LTM) Verileri olarak bilinir. Daha fazla bilgi edinin.

Analiz Modeli ve Kar Tanesi

Bu raporu oluşturmak için kullanılan analiz modelinin ayrıntılarına GitHub sayfamızdan ulaşabilirsiniz, ayrıca raporlarımızı nasıl kullanacağınızı anlatan kılavuzlarımız ve Youtube'da eğitim videolarımız da bulunmaktadır.

Simply Wall St analiz modelini tasarlayan ve oluşturan dünya standartlarındaki ekip hakkında bilgi edinin.

Endüstri ve Sektör Metrikleri

Sektör ve bölüm metriklerimiz Simply Wall St tarafından her 6 saatte bir hesaplanmaktadır, sürecimizin ayrıntıları Github'da mevcuttur.

Analist Kaynakları

The Procter & Gamble Company 43 Bu analistlerden 21, raporumuzun girdisi olarak kullanılan gelir veya kazanç tahminlerini sunmuştur. Analistlerin gönderimleri gün boyunca güncellenmektedir.

AnalistKurum
Christopher GrajaArgus Research Company
Lauren LiebermanBarclays
Lauren LiebermanBarclays